CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE:MZOR), a developer of innovative surgical robots and complementary products, today announced its financial results for the third quarter and nine months ending September 30, 2011. “While the number of our surgical robot systems sold during the third quarter remained flat with the year ago period, system utilization continues to increase, especially at U.S. installations,” said Ori Hadomi, President & CEO. “In recent weeks, the annualized average number of cases per installation has risen from approximately 45 one year ago to nearly 80. This utilization growth rate compares favorably with the early adoption trends of other robotic medical devices. We remain the only robotic medical device company focused on the spine and brain, and our momentum in the spine market is increasing during the current fourth quarter.”
